Moreover, one of the key COVID-19-induced compensatory gene pathways include the enhanced expression of UBE3A which drives a ubiquitin-modulated host response to COVID-19 and is positively associated with reduced disease severity. The gene discussed is UBE3A; the disease is COVID-19.